Abstract:Abstract Background Inflammatory bowel diseases encompass two pathologies affecting the digestive tract, Crohn’s disease (CD) and ulcerative colitis (UC). They are characterized by a high and chronic inflammatory rate, resulting from activation of the intestinal immune system and increased permeability of the intestinal barrier leading to lesions in the intestinal tract. Non-classical CD14- CD16+ monocytes, are recruited to the focus of inflammation from the peripheral blood and preferentially differentiate to anti-inflammatory macrophages CD206+ CD163+ HLA-DR- in the intestine, playing a key role in the repair of such lesions. In some cases, treatment with biologics, such as vedolizumab, could interfere with this biological process leading to a modification of the innate immune response. Previous results showed that CD and UC had a different distribution of non-classicalmonocytes, leading to the hypothesis that treatment with biologic could modulate macrophage wound healing response. Methods Macrophages derived by THP-1 cells were polarized to M0, after PMA treatment, followed by LPS and IFN-γ for M1 macrophages, or IL-4 and IL-13 for M2 macrophages. To assess the effect of biologics on macrophage immune response, Infliximab (IFX) and Vedolizumab (VDZ) were added independently to the cell cultures until polarization process finalized. Immunophenotyping of M0, M1 and M2, and transcription factor expression profiling of pSTAT-1, pSTAT-6 and pNFκB, were carried out by flow cytometry. Cytokine production of IL-6, TGF-β and IL-10, was performed by ELISA immunoblot. Macrophages immune response was assessed with wound healing assay with Caco-2. Results Immunophenotyping revealed that M1 macrophages increased the expression of surface markers like HLA-DR, CD38 and reduced CD11c, vs. M0 macrophages, indeed transcription factor expression of pSTAT-6 and pNFκB were modulated. M2 macrophages showed the decrease of CD163 and HLA-DR vs. M0 macrophages, while no significant effect was observed for CD38 and CD206. Transcription factor expression revealed that pSTAT 6 incremented vs. M0. Cytokine profiling showed a clear difference between the tree macrophages types. Finally wound healing assay with Caco-2 revealed how biologic interfered with innate immune response. Conclusion Our results demonstrated that the treatment administration could be responsible of macrophage differential immune response, especially upon biologic treatment. These findings could lead to support the establishment of precision medicine in order to modulate a suitable macrophage response.

The Differential Effect of a Shortage of Thyroid Hormone Compared with Knockout of Thyroid Hormone Transporters Mct8 and Mct10 on Murine Macrophage Polarization

THP-1 and human peripheral blood mononuclear cell-derived macrophages differ in their capacity to polarize in vitro

Lack of the Thyroid Hormone Transporter Mct8 in Osteoblast and Osteoclast Progenitors Increases Trabecular Bone in Male Mice

The role of transducin β-like 1 X-linked receptor 1 (TBL1XR1) in thyroid hormone metabolism and action in mice

Characterization of polarized THP-1 macrophages and polarizing ability of LPS and food compounds

Convenience versus Biological Significance: Are PMA-Differentiated THP-1 Cells a Reliable Substitute for Blood-Derived Macrophages When Studying in Vitro Polarization?

Thyroxine is a potential endogenous antagonist of macrophage migration inhibitory factor (MIF) activity

M2-like polarization of THP-1 monocyte-derived macrophages under chronic iron overload

M1 and M2 Macrophage Polarization and Potentially Therapeutic Naturally Occurring Compounds.

THP-1 Monocytic Cells Are Polarized to More Antitumorigenic Macrophages by Serial Treatment with Phorbol-12-Myristate-13-Acetate and PD98059

Cellular zinc homeostasis modulates polarization of THP-1-derived macrophages

Reduced PMA enhances the responsiveness of transfected THP-1 macrophages to polarizing stimuli

P047 Effect of infliximab and vedolizumab on M1 and M2 macrophages derived from THP-1 cells

Senescent thyrocytes and thyroid tumor cells induce M2-like macrophage polarization of human monocytes via a PGE2-dependent mechanism

Comparative Proteomic Analysis Reveals Varying Impact on Immune Responses in Phorbol 12-Myristate-13-Acetate-Mediated THP-1 Monocyte-to-Macrophage Differentiation

Differential susceptibility to lipopolysaccharide affects the activation of toll-like-receptor 4 signaling in THP-1 cells and PMA-differentiated THP-1 cells

CYP2C19 Contributes to THP-1-Cell-Derived M2 Macrophage Polarization by Producing 11,12- and 14,15-Epoxyeicosatrienoic Acid, Agonists of the PPARγ Receptor

TSH Activates Macrophage Inflammation by G13- and G15-dependent Pathways

Metabolic Effects of the Intracellular Regulation of Thyroid Hormone: Old Players, New Concepts

Changes in the proteomic profile during the differential polarization status of the human monocyte-derived macrophage THP-1 cell line.

The Role of Indoleamine 2,3-Dioxygenase (IDO) in Immune Tolerance: Focus on Macrophage Polarization of THP-1 Cells.